Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New program aims to curb suicide risk in teens on probation

NCT ID NCT07559955

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 31, 2026 · Updated 5 times

Summary

This study tests a program called Youth-Nominated Support Team for Probation (YST-P) for teens aged 12-17 who are on probation and have suicidal thoughts or behaviors. The program connects them with supportive adults to reduce suicide risk and encourage them to get mental health treatment. About 40 teens will participate, and researchers will compare their progress to similar teens who did not receive the program.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 137 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Feb 2027

An estimate. Start dates often move.

Expected to finish

Jul 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

12 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: YST-P Pilot Youth on probation, referred to study by YST Intervention Specialist (n=40) 1. Conversational in English (self-report/caregiver) 2. Age 12-17years 11months (self-report/caregiver) 3. Probation involvement (probation staff) 4. Have a caregiver who is willing to participate (caregiver) 5. Endorsed PY suicidal ideation (probation staff) 6. Nominated 2-4 supportive adults, at least 2 of whom are willing to participate (Intervention Specialist, supportive adult) Caregivers, referred to study by YST Intervention Specialist (n=40) 1. Conversational in English (self-report) 2. Caregiver of a youth who is eligible and willing to participate (probation referral, youth report) Supportive adults, referred to study by YST Intervention Specialist (n=40) 1. Participating as a supportive adult in YST-P as indicated by completion of YST-P psychoeducational session (Intervention Specialist report) 2. Conversational in English (self-report) 3. Approved by youths' caregiver (caregiver) 4. Be appropriate as determined by the YST-P Intervention Specialist (Intervention Specialist). Probation staff, assisted by agency leadership (n=15) 1. Conversational in English (self-report) 2. Employed by Suffolk or Nassau County Probation working with youth (self-report/agency leadership) Intervention Specialists, assisted by agency leadership (n=2) 1. Conversational in English (self-report) 2. Employed by Hope for Youth Licensed behavioral health clinician (self-report/agency leadership) 3. Trained as YST-P Intervention Specialists (Research team) 4. Facilitating the YST-P intervention (Research team) Exclusion Criteria: \- Participants not meeting all inclusion criteria will be excluded from research activities.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Suicidal ideation and behavior are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Behavior Psychological Well-Being Suicidal Ideation Suicide

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Columbia University Irving Medical Center (CUIMC) Alianza Dominicana Triangle Building

    RECRUITING

    New York, New York, 10032, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.